Health and Wellness
Baringo selected for first Kala-azar vaccine trial at Chemolingot centre
The Kenya Medical Research Institute (Kemri) will run the study at the Chemolingot Kala-azar Centre in Tiaty Central, an area that continues to report some of the highest infection levels in the country.
